Antiviral dendrimers
US6190650A · kind A · utility
41Cited by
1References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 1997 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Apr 28, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antiviral compound comprises a dendrimer such as a polyamidoamine or polyly sine dendrimer having a plurality of terminal groups, wherein at least one of the terminal groups has an anionic- or cationic-containing moiety bonded thereto, particularly a sulfonic acid-containing, carboxylic acid-containing or trimethylammonium-containing moiety or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.